Related Experiment Videos
Oncogene products represent potential targets of tumor vaccines
1Department of Surgery, Park Nicollet Clinic, Minneapolis, MN 55416, USA.
Cancer Immunology, Immunotherapy : CII
|November 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The association of new-onset diabetes with subsequent diagnosis of pancreatic cancer-novel use of a large administrative database.
Journal of public health (Oxford, England)·2022
Axillary web syndrome following breast cancer surgery: symptoms, complications, and management strategies.
Breast cancer (Dove Medical Press)·2018
Quality-of-life implications of risk-reducing cancer surgery.
The British journal of surgery·2018
Surgery alone is adequate treatment for early stage soft tissue sarcoma of the extremity.
The British journal of surgery·2010
Feasibility of single-voxel MRS measurement of apparent diffusion coefficient of water in breast tumors.
Magnetic resonance in medicine·2009
Sentinel lymph node biopsy. Preferred method of axillary staging for breast cancer.
Minerva ginecologica·2005
The CREM-IL-15 axis: decoding the persistence-exhaustion paradox in NK cell immunotherapy.
Cancer immunology, immunotherapy : CII·2026
Therapeutic targeting of CD47 using a tri-specific NK cell engager to inhibit multiple myeloma.
Cancer immunology, immunotherapy : CII·2026
Mast cells in tumors: dual roles and therapeutic potential.
Cancer immunology, immunotherapy : CII·2026
Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma.
Cancer immunology, immunotherapy : CII·2026
HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression.
Cancer immunology, immunotherapy : CII·2026
TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.
The Journal of experimental medicine·2026
Activation of PP2A-B56a leads to aberrant EGFR signaling and proliferative phenotypes in PDAC.
Molecular cancer therapeutics·2026
Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset.
Clinical pharmacology and therapeutics·2026
Payload-Free [89Zr]Zr-DFO*-sq-Enfortumab ImmunoPET for Imaging Nectin-4 Expression in Bladder Cancer.
Molecular pharmaceutics·2026